EichorEICHOR
Location: Seongnam Si Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Seongnam Si

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Eli Lilly and Company · NCT06338995A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-108
Phase 3 · Merck Sharp & Dohme LLC · NCT06997497A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07063745A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresec
Phase 3 · Bristol-Myers Squibb · NCT07361497Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Preve
Phase N/A · AbbVie · NCT06603558A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Phase 2/Phase 3 · Janssen Research & Development, LLC · NCT07196722
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.